Achromatopsia 6
MONDO:0012398Any achromatopsia caused by a mutation in the PDE6H gene, characterized by incomplete loss of color vision, with a red-green color vision defect and normal or near-normal blue-yellow vision. Reduced visual acuity is also present, but not progressive.
Also known as: ACHM6, RCD3A, retinal cone dystrophy 3A, retinal cone dystrophy type 3A
27 clinical trials for this condition and its sub-types, 0 tagged with Achromatopsia 6 itself.
Follow this condition to get notified about new trialsWhere it sits in the disease tree
Browse by category →-
Could a smartphone app help babies see better?
Disease control Not yet recruitingThis study tests a caregiver-led digital program called VIPPSTAR designed to improve vision and brain development in infants at risk of or with visual impairment. The program provides personalized activities integrated into daily routines, supported by remote coaching. Researcher…
Sponsor: Università degli Studi di Brescia • Aim: Disease control
Last updated Jul 23, 2026 00:00 UTC
-
Adapted exercise program aims to boost health and social skills in visually impaired youth
Symptom relief Not yet recruitingThis study tests a 12-week adapted physical activity program for children and adolescents aged 10-17 with visual impairment. The program includes supervised school-based exercise sessions and home-based activities, along with peer-group meetings to promote social inclusion. Resea…
Sponsor: Università degli Studi di Trento • Aim: Symptom relief
Last updated Jul 16, 2026 00:00 UTC
-
New wearable gadget aims to give Low-Vision users a helping hand
Symptom relief Not yet recruitingThis study explores how visual impairment affects movement and daily activities, and tests a wearable system called VIS4ION that provides audio and touch cues to help users navigate. Researchers will enroll 150 adults with visual impairment and healthy controls to see if the devi…
Sponsor: NYU Langone Health • Aim: Symptom relief
Last updated Jun 27, 2026 09:09 UTC
-
New eye camera could spot retinal disease earlier
Knowledge-focused Not yet recruitingThis study will test a new, noninvasive camera called XyCAM CRE that measures blood flow in the back of the eye. Researchers will compare its images with standard eye tests in 350 adults with retinal disorders. The goal is to see if this camera can provide extra information to he…
Sponsor: Stuart Terry Eye Associates • Aim: Knowledge-focused
Last updated Jun 27, 2026 13:07 UTC